ACTN2 and restrictive cardiomyopathy: We also identified a variant in a miRNA binding site of ACTN2 (chr1:236927207), a gene for which we and others recently demonstrated that protein-truncating variants cause hypertrophy and restrictive cardiomyopathy (RCM) in humans (59).